Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion

被引:62
|
作者
Barber, DF
Bartolomé, A
Hernandez, C
Flores, JM
Fernandez-Arias, C
Rodríguez-Borlado, L
Hirsch, E
Wymann, M
Balomenos, D
Carrera, AC
机构
[1] Univ Autonoma Madrid, Dept Immunol & Oncol, E-28049 Madrid, Spain
[2] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Anim Facil, E-28049 Madrid, Spain
[3] Univ Complutense Madrid, Sch Vet, Dept Anim Med & Surg, E-28040 Madrid, Spain
[4] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[5] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 01期
关键词
D O I
10.4049/jimmunol.176.1.589
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I PI3K catalyzes formation of 3-poly-phosphoinositides. The family is divided into I-A isoforms, activated by Tyr kinases and I-A the I-B isoform (PI3K gamma), activated by G protein-coupled receptors. Mutations that affect PI3K are implicated in chronic inflammation, although the differential contribution of each isoform to pathology has not been elucidated. Enhanced activation of class I-A-PI3K in T cells extends CD4(+) memory cell survival, triggering an invasive lymphoproliferative disorder and systemic lupus. As both I-A- and 1(B)-PI3K isoforms regulate T cell activation, and activated pathogenic CD4(+) memory cells are involved in triggering systemic lupus, we examined whether deletion of I-B could reduce the pathological consequences of increased I-A-PI3K activity. I-B-PI3K gamma deficiency did not abolish invasion or lymphoproliferation, but reduced CD4(+) memory cell survival, autoantibody production, glomerulonephritis, and systemic lupus. Deletion of the I-B-PI3K gamma isoform thus decreased survival of pathogenic CD4(+) memory cells, selectively inhibiting systemic lupus development. These results validate the PI3K gamma isoform as a target for systemic lupus erythernatosus treatment.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 50 条
  • [21] Crucial Role of Class IB PI3-Kinase, PI3Kγ, in Obesity-Induced Insulin Resistance
    Kobayashi, Naoki
    Ueki, Kohjiro
    Sasaki, Takehiko
    Kadowaki, Takashi
    DIABETES, 2009, 58 : A352 - A352
  • [22] Regulatory Subunits of Class IA PI3K
    Fruman, David A.
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 225 - 244
  • [23] Phosphoinositide 3-kinase δ (PI3Kδ) in respiratory disease
    Stokes, Clare A.
    Condliffe, Alison M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 361 - 369
  • [24] Synthesis of Phosphatidylinositol 3-Kinase (PI3K) Inhibitory Analogues of the Sponge Meroterpenoid Liphagal
    Pereira, Alban R.
    Strangman, Wendy K.
    Marion, Frederic
    Feldberg, Larry
    Roll, Deborah
    Mallon, Robert
    Hollander, Irwin
    Andersen, Raymond J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (24) : 8523 - 8533
  • [25] Role of phosphatidylinositol 3-kinaseγ (PI3Kγ) in mediating lung inflammatory injury via neutrophil-endothelial cell interaction:: Studies in PI3Kγ -/- mice
    Ong, ES
    Gao, XP
    Javaid, K
    Ye, R
    Jho, DH
    Malik, AB
    FASEB JOURNAL, 2002, 16 (05): : A1150 - A1151
  • [26] Impact of the phosphatidylinositol 3-kinase (PI3K) pathway on cytokine generation by human neutrophils
    Fortin, Carl F.
    McDonald, Patrick P.
    CYTOKINE, 2009, 48 (1-2) : 82 - 83
  • [27] Inhibition of phosphatidylinositol 3-kinase (PI3K) improves contractility in α-adrenergic stimulated myocardium
    Jacobshagen, Claudius
    Kortlepel, Swantje
    Unsoeld, Bernhard W.
    Kogler, Harald
    Hasenfuss, Gerd
    Maier, Lars S.
    CIRCULATION, 2007, 116 (16) : 290 - 291
  • [28] The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer
    Naumann, R. Wendel
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 411 - 420
  • [29] The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria
    Tsuruta, F
    Masuyama, N
    Gotoh, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 14040 - 14047
  • [30] Development of a novel PET tracer targeting phosphatidylinositol 3-kinase (PI3K) in tumor
    Makino, A.
    Arai, T.
    Temma, T.
    Hirata, M.
    Ono, M.
    Ohmomo, Y.
    Saji, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S450 - S450